Randomized Trial of Fish Oil Versus Placebo to Reduce ALT Levels in Overweight Adolescents

Trial Profile

Randomized Trial of Fish Oil Versus Placebo to Reduce ALT Levels in Overweight Adolescents

Discontinued
Phase of Trial: Phase I

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Omega-3-acid ethyl esters (Primary)
  • Indications Fatty liver; Non-alcoholic fatty liver disease
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 12 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top